Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,700 | 24 | 74.2% |
| Travel and Lodging | $5,693 | 15 | 10.4% |
| Consulting Fee | $5,620 | 3 | 10.2% |
| Food and Beverage | $2,831 | 31 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $49,419 | 60 | $0 (2024) |
| PFIZER INC. | $2,085 | 4 | $0 (2024) |
| Visby Medical, Inc. | $1,738 | 2 | $0 (2023) |
| Abbott Laboratories | $1,538 | 5 | $0 (2024) |
| Novo Nordisk Inc | $64.66 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,715 | 57 | AstraZeneca Pharmaceuticals LP ($45,213) |
| 2023 | $6,082 | 15 | AstraZeneca Pharmaceuticals LP ($4,206) |
| 2019 | $47.62 | 1 | Novo Nordisk Inc ($47.62) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $946.40 | General |
| 12/11/2024 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $430.47 | General |
| 12/11/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $427.75 | General |
| 12/11/2024 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $280.35 | General |
| 12/04/2024 | Abbott Laboratories | BINAXNOW STREPTOCOCCUS PNEUMONIAE ANTIGEN CARD (Device) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Rapid Diagnostics | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $653.92 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $97.73 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $52.46 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $117.19 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Respiratory | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $359.79 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $176.88 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $118.36 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $2.37 | General |
| Category: Respiratory | ||||||
| 10/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $596.18 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 360 | 370 | $53,997 | $18,546 |
| 2022 | 8 | 309 | 316 | $50,155 | $17,350 |
| 2021 | 5 | 156 | 161 | $28,942 | $10,155 |
| 2020 | 6 | 198 | 200 | $33,535 | $9,280 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 127 | $19,812 | $7,616 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 67 | 67 | $17,152 | $4,321 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 38 | $8,170 | $3,650 | 44.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 37 | 37 | $2,590 | $1,733 | 66.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 39 | 40 | $3,640 | $928.44 | 25.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 22 | $1,892 | $212.70 | 11.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 37 | 39 | $741.00 | $85.80 | 11.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 77 | 77 | $19,712 | $5,723 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 80 | $12,480 | $5,227 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 51 | $10,965 | $4,435 | 40.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 32 | 32 | $2,912 | $733.82 | 25.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 20 | 20 | $1,400 | $607.64 | 43.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 11 | 11 | $759.00 | $382.96 | 50.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $1,376 | $177.85 | 12.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 27 | 29 | $551.00 | $62.39 | 11.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 62 | 62 | $15,872 | $5,036 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 33 | $7,095 | $3,025 | 42.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 25 | $3,900 | $1,603 | 41.1% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 16 | 18 | $1,638 | $438.09 | 26.7% |
| 81003 | Automated urinalysis test | Office | 2021 | 22 | 23 | $437.00 | $51.75 | 11.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 54 | 54 | $13,824 | $3,544 | 25.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 45 | 47 | $10,105 | $3,164 | 31.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 43 | 43 | $6,708 | $2,070 | 30.9% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 14 | 14 | $1,229 | $304.85 | 24.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 13 | 13 | $1,118 | $132.05 | 11.8% |
About Dr. Christopher Chao, MD
Dr. Christopher Chao, MD is a Family Medicine healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720061435.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Chao, MD has received a total of $54,844 in payments from pharmaceutical and medical device companies, with $48,715 received in 2024. These payments were reported across 73 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($40,700).
As a Medicare-enrolled provider, Chao has provided services to 1,023 Medicare beneficiaries, totaling 1,047 services with total Medicare billing of $55,331. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cary, NC
- Active Since 11/28/2005
- Last Updated 02/17/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1720061435
Products in Payments
- AIRSUPRA (Drug) $46,584
- VISBY MEDICAL SEXUAL HEALTH CLICK TEST (Device) $1,738
- BINAXNOW STREPTOCOCCUS PNEUMONIAE ANTIGEN CARD (Device) $1,400
- ALINITY (Device) $88.74
- I-STAT (Device) $49.16
- Ozempic (Drug) $47.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cary
Charlie Foster, Md, MD
Family Medicine — Payments: $26,014
Jing Zhang, Md, MD
Family Medicine — Payments: $25,051
Dr. David Adams, Md, MD
Family Medicine — Payments: $22,117
Mr. Joseph Bruckert, M.d, M.D
Family Medicine — Payments: $19,360
Dr. Corey Musselman, M.d, M.D
Family Medicine — Payments: $15,244
Dr. Justin Glodowski, D.o, D.O
Family Medicine — Payments: $13,579